# Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)

> **NCT00453804** · PHASE4 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 15 (—)

## Conditions studied

- Bipolar Disorders
- Schizophrenia
- Schizoaffective Disorders
- Alcohol Dependence

## Interventions

- **DRUG:** injectable naltrexone
- **DRUG:** oral naltrexone

## Key facts

- **NCT ID:** NCT00453804
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 15 (—)
- **Last updated:** 2008-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453804, "Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00453804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*